Cogint, Inc. Announces Corporate Name Change to Fluent, Inc.
Cogent Biosciences, Inc. (COGT)
Last cogent biosciences, inc. earnings: 11/8 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.cogint.com/investor-relations
Company Research
Source: GlobeNewswire
NEW YORK, April 11, 2018 (GLOBE NEWSWIRE) -- Cogint, Inc. (NASDAQ:COGT), a leading data-driven marketing services firm uniquely built on a pay-for-performance model, today announced it will change its name to Fluent, Inc. This rebranding is the culmination of recent strategic changes at the company, including the successful spin off of Red Violet (NASDAQ:RDVT), the appointment of former Merkle COO, Don Patrick to its Executive team and the appointment of former Epsilon CEO, Andy Frawley, to its board of directors. As part of the name change, the Company will continue to be publicly traded on the NASDAQ Global Market (the “NASDAQ”) under the new ticker symbol “FLNT”. “We’re thrilled to announce our name change,” said Ryan Schulke, CEO. “This strategic branding decision comes at a natural inflection point for Fluent and our brand. Since entering the public market in 2015 we have continued to execute exceptionally on our roadmap and are excited to introduce the Fluent brand to Wall S
Show less
Read more
Impact Snapshot
Event Time:
COGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COGT alerts
High impacting Cogent Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
COGT
News
- Cogent Biosciences, Inc. (NASDAQ: COGT) had its "buy" rating re-affirmed by analysts at HC Wainwright.MarketBeat
- Cogent Biosciences, Inc. (NASDAQ: COGT) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.MarketBeat
- Cogent Biosciences, Inc. (NASDAQ: COGT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.MarketBeat
- Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis PatientsGlobeNewswire
- Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)GlobeNewswire
COGT
Earnings
- 11/12/24 - Miss
COGT
Sec Filings
- 12/9/24 - Form 8-K
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- COGT's page on the SEC website